Regeneron Pharmaceuticals Inc
LSE:0R2M
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
|
C
|
CELSYS Inc
TSE:3663
|
JP |
|
Sands China Ltd
F:599A
|
MO |
|
H
|
Highland Copper Company Inc
OTC:HDRSF
|
CA |
|
K
|
Keyera Corp
OTC:KEYUF
|
CA |
|
DENTSPLY SIRONA Inc
F:DY2
|
US |
|
D
|
DSC Investment Inc
KOSDAQ:241520
|
KR |
|
Sartorius AG
F:SRT4
|
DE |
|
P
|
Pennant Group Inc
NASDAQ:PNTG
|
US |
|
K
|
Kao Corp
XMUN:KAO
|
JP |
|
L
|
Lowe's Companies Inc
F:LWE
|
US |
|
G
|
G8 Education Ltd
SWB:3EAG
|
AU |
|
R
|
Relx PLC
XMUN:RDEB
|
UK |
|
N
|
NEC Corp
DUS:NEC1
|
JP |
|
Yokogawa Electric Corp
TSE:6841
|
JP |
|
U
|
Uber Technologies Inc
F:UT8
|
US |
|
Johnson Health Tech Co Ltd
TWSE:1736
|
TW |
|
I
|
Icade SA
F:3IC
|
FR |
|
Daiwa House Industry Co Ltd
F:DWH
|
JP |
|
Shandong Linglong Tyre Co Ltd
SSE:601966
|
CN |
|
A
|
Alliant Energy Corp
F:AY1
|
US |
|
A
|
Akobo Minerals AB (publ)
OSE:AKOBO
|
SE |
|
Braime Group PLC
LSE:BMTO
|
UK |
|
Clean Seed Capital Group Ltd
XTSX:CSX
|
CA |
Dividends
Dividend Yield
Regeneron Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Regeneron Pharmaceuticals Inc
0R2M have decreased by 0%.
Payout Ratio
Regeneron Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 0R2M is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0R2M Price
Regeneron Pharmaceuticals Inc
| Average Annual Return | -1.62% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -27% |
| Market Capitalization | 78.4B USD |
| Shares Outstanding | 105 100 000 |
| Percentage of Shares Shorted |
N/A
|
